|
1H4R
Crystal Structure of the FERM domain of Merlin, the Neurofibromatosis 2 Tumor Suppressor Protein.
Deposited 2001-05-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–313(313 aa)
Fragment:FERM DOMAIN RESIDUES 1-313
Chain B
1–313(313 aa)
Fragment:FERM DOMAIN RESIDUES 1-313
|
Not recorded
|
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;THE PROTEIN WAS CRYSTALLIZED USING HANGING-DROP VAPOR DIFFUSION WIHTH 56% AMMONIUM SULFATE, 2% DIOXANE, 100 MM CACODYLATE, PH 6.5. A 1:1 RATIO OF PROTEIN TO WELL SOLUTION WAS USED.
|
Resolution 1.80 Å
R-free 0.227
|
|
3U8Z
human merlin FERM domain
Deposited 2011-10-17
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
18–312(295 aa)
Fragment:FERM domain (UNP residues 20-312)
Chain C
18–312(295 aa)
Fragment:FERM domain (UNP residues 20-312)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;protein in 50 mM Tris, pH 8.0, 300 mM sodium chloride, reservoir: 4.5% PEG4000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.64 Å
R-free 0.229
|
|
3U8Z
human merlin FERM domain
Deposited 2011-10-17
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
18–312(295 aa)
Fragment:FERM domain (UNP residues 20-312)
Chain D
18–312(295 aa)
Fragment:FERM domain (UNP residues 20-312)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;protein in 50 mM Tris, pH 8.0, 300 mM sodium chloride, reservoir: 4.5% PEG4000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.64 Å
R-free 0.229
|
|
4ZRI
Crystal structure of Merlin-FERM and Lats2
Deposited 2015-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–320(320 aa)
Fragment:FERM domain, UNP residues 1-320
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;18% iso-Propanol, 0.1M Tris, 5% PEG8000
|
Resolution 2.70 Å
R-free 0.270
|
|
4ZRI
Crystal structure of Merlin-FERM and Lats2
Deposited 2015-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–320(320 aa)
Fragment:FERM domain, UNP residues 1-320
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;18% iso-Propanol, 0.1M Tris, 5% PEG8000
|
Resolution 2.70 Å
R-free 0.270
|
|
6CDS
Human neurofibromin 2/merlin/schwannomin residues 1-339 in complex with PIP2
Deposited 2018-02-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–339(339 aa)
|
Mutation:G302E
|
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 1
PO4 PHOSPHATE ION × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;100 mM HEPES (pH 7.5), 50 mM MgCl2(H2O)6, 35 % PEG 550 monomethyl ether
|
Resolution 2.62 Å
R-free 0.237
|
|
6CDS
Human neurofibromin 2/merlin/schwannomin residues 1-339 in complex with PIP2
Deposited 2018-02-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–339(339 aa)
|
Mutation:G302E
|
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 1
PO4 PHOSPHATE ION × 1
PEG DI(HYDROXYETHYL)ETHER × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;100 mM HEPES (pH 7.5), 50 mM MgCl2(H2O)6, 35 % PEG 550 monomethyl ether
|
Resolution 2.62 Å
R-free 0.237
|
|
7LWH
Human neurofibromin 2/merlin residues 1-339 in complex with LATS1
Deposited 2021-03-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–339(339 aa)
|
Not recorded
|
IMD IMIDAZOLE × 3
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;600 mM imidazole (pH 6.5), 15% (w/v) polyethylene glycol 3,350
|
Resolution 1.61 Å
R-free 0.233
|